Sandra Prior
Overview
Explore the profile of Sandra Prior including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
153
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tounekti O, Prior S, Wassmer S, Xu J, Wong A, Fang X, et al.
Bioanalysis
. 2025 Jan;
17(3):105-149.
PMID: 39862111
The 18 Workshop on Recent Issues in Bioanalysis (18 WRIB) took place in San Antonio, TX, USA on May 6-10, 2024. Over 1100 professionals representing pharma/biotech companies, CROs, and multiple...
2.
Sajjadi N, Brady R, Jungback C, Mallet L, Milne C, Prior S, et al.
Biologicals
. 2024 Mar;
86:101756.
PMID: 38479213
An international hybrid meeting held 21-22 June 2023 in Ottawa, Canada brought together regulators, scientists, and industry experts to discuss a set of principles and best practices in the development...
3.
Manak M, Gagnon L, Phay-Tran S, Levesque-Damphousse P, Fabie A, Daugan M, et al.
Lancet Microbe
. 2024 Jan;
5(3):e216-e225.
PMID: 38278167
Background: Accurate quantitation of immune markers is crucial for ensuring reliable assessment of vaccine efficacy against infectious diseases. This study was designed to confirm standardised performance of SARS-CoV-2 assays used...
4.
Berry N, Ferguson D, Kempster S, Hall J, Ham C, Jenkins A, et al.
Sci Rep
. 2022 Nov;
12(1):18694.
PMID: 36333445
SARS-CoV-2 exhibits a diverse host species range with variable outcomes, enabling differential host susceptibility studies to assess suitability for pre-clinical countermeasure and pathogenesis studies. Baseline virological, molecular and pathological outcomes...
5.
Kaur S, Alley S, Szapacs M, Wilson A, Ciccimaro E, Su D, et al.
Bioanalysis
. 2022 May;
14(9):505-580.
PMID: 35578993
The 15th edition of the Workshop on Recent Issues in Bioanalysis (15th WRIB) was held on 27 September to 1 October 2021. Even with a last-minute move from in-person to...
6.
Hersey S, Keller S, Mathews J, King L, Bandukwala A, Berisha F, et al.
Bioanalysis
. 2022 May;
14(10):627-692.
PMID: 35578974
The 15th edition of the Workshop on Recent Issues in Bioanalysis (15th WRIB) was held on 27 September to 1 October 2021. Even with a last-minute move from in-person to...
7.
Prior S, Metcalfe C, Hufton S, Wadhwa M, Schneider C, Burns C
Nat Biotechnol
. 2021 Mar;
39(3):276-280.
PMID: 33664522
No abstract available.
8.
Prior S, Hufton S, Fox B, Dougall T, Rigsby P, Bristow A
MAbs
. 2017 Oct;
10(1):129-142.
PMID: 28985159
The intrinsic complexity and heterogeneity of therapeutic monoclonal antibodies is built into the biosimilarity paradigm where critical quality attributes are controlled in exhaustive comparability studies with the reference medicinal product....
9.
Salazar-Fontana L, Desai D, Khan T, Pillutla R, Prior S, Ramakrishnan R, et al.
AAPS J
. 2017 Jan;
19(2):377-385.
PMID: 28083796
All biotherapeutics have the potential to induce an immune response. This immunological response is complex and, in addition to antibody formation, involves T cell activation and innate immune responses that...
10.
Cheung G, Kelly S, Jess T, Prior S, Price N, Parton R, et al.
Microb Pathog
. 2008 Nov;
46(1):36-42.
PMID: 18992319
A comparison was made of the cytotoxic activity and secondary structural features of four recombinant forms of adenylate cyclase toxin (CyaA). These forms were fully functional CyaA, CyaA lacking adenylate...